𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The detection of minimal residual disease status in chronic lymphocytic leukemia

✍ Scribed by Gerald E. Marti

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
51 KB
Volume
80B
Category
Article
ISSN
1552-4949

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Detection of minimal residual disease in
Detection of minimal residual disease in acute leukemia by flow cytometry
✍ Dario Campana; Elaine Coustan-Smith πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 289 KB πŸ‘ 2 views

Patients with acute leukemia in clinical remission may still have up to 10 10 residual malignant cells (the upper limit of detection by standard morphologic techniques). Sensitive techniques to detect minimal residual disease (MRD) may allow better estimates of the leukemia burden and help the selec

Alemtuzumab as treatment for residual di
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia
✍ Susan M. O'Brien; Hagop M. Kantarjian; Deborah A. Thomas; Jorge Cortes; Francis πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The objective of this study was to investigate the efficacy and safety of alemtuzumab, the humanized anti‐CD52 monoclonal antibody, in patients with B‐cell chronic lymphocytic leukemia and residual disease after chemotherapy. ## METHODS Forty‐one patients received alemt